Globus Medical, Inc. GMED
Globus Medical, Inc. (NYSE: GMED) is a medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Spinal implants, orthopedic trauma, hip and knee arthroplasty | Musculoskeletal disorders | — | NA_NON_THERAPEUTIC |
| Excelsius ecosystem (ExcelsiusGPS, Excelsius XR) imaging/navigation/robotics | Computer-assisted surgery | — | NA_NON_THERAPEUTIC |
| Nevro HFX / Senza spinal cord stimulation (Class III, PMA) | Chronic pain | — | NA_NON_THERAPEUTIC |
| Regenerative biologics / HCT/Ps (Osteocel) | Spinal fusion | — | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.